RAB7A and cancer: Modulation of Rab7a activity affects a number of disease pathologies including neuropathies and neurodegenerative diseases such as Charcot-Marie-Tooth type 2B, hereditary sensory neuropathy type 1, and Niemann Pick type C1 (NPC1), infectious diseases, and cancer, including melanoma5–10.